Bringing the fundamentals into focus…
Back to Sanofi
How Sanofi stacks up
SNY · against 33 other Healthcare companies of similar size
Overall
66/ 100
Above the middle of the pack.
Ranked #10 of 34 · scores higher than 73% of peers
Bars: peers in each 10-point band of the overall score9 peers with an overall score of 60–69, including SNY · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around SNY| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 56.7B USD | 79 | 42 | 96 | 93 | 0 / 2 | |
| 2 | 534.1B HKD (≈$68.4B) | 75 | 72 | 76 | 96 | 1 / 2 | |
| 2 | 8.24T JPY (≈$56.0B) | 75 | 57 | 63 | 98 | 0 / 2 | |
| 4 | 11.26T JPY (≈$76.6B) | 72 | 71 | 44 | 99 | 0 / 2 | |
| 5 | 177.5B USD | 71 | 92 | 60 | 99 | 2 / 2 | |
| 5 | 52.7B EUR (≈$58.0B) | 71 | 69 | 76 | 87 | 1 / 2 | |
| 7 | 134.5B USD | 70 | 55 | 58 | 96 | 0 / 2 | |
| 8 | 100.2B USD | 68 | 61 | 49 | 85 | 0 / 2 | |
| 9 | 97.5B USD | 67 | 87 | 72 | 89 | 2 / 2 | |
| 10 | 108.6B USD | 66 | 88 | 55 | 72 | 1 / 2 | |
| 11 | 63.0B USD | 65 | 74 | 73 | 79 | 1 / 2 | |
| 12 | 540.4B BRL (≈$97.3B) | 64 | 83 | 72 | 79 | 2 / 2 | |
| 12 | 155.7B USD | 64 | 47 | 73 | 94 | 1 / 2 | |
| 14 | 162.93T ARS (≈$162.9B) | 63 | 82 | 72 | 78 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score